Can-Fite BioPharma Ltd. (CANF) Net margin 2017–2025
Can-Fite BioPharma Ltd. (CANF) net profit margin by fiscal year — reported net income divided by reported revenue.
-2426.7%FY2025 · since FY2017: -613.7% → -2426.7%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -2426.7% | -1257.5 pp |
| FY2024 | -1169.1% | -141.7 pp |
| FY2023 | -1027.5% | +228.5 pp |
| FY2022 | -1255.9% | +223.0 pp |
| FY2021 | -1478.9% | +414.0 pp |
| FY2020 | -1892.9% | -1271.6 pp |
| FY2019 | -621.3% | -449.3 pp |
| FY2018 | -172.0% | +441.7 pp |
| FY2017 | -613.7% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice